CIK 0001672619
- Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811523849
- Phone
- +1 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $39.79 ($198,971)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at an average $47.67 ($238,352)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 40,000 shares at $35.10 ($1,404,024)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 5,000 shares at $27.76 ($138,800)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 40,000 shares at an average $30.07 ($1,202,638)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 10,000 shares at $29.58 ($295,839)
- 4 Planned sale Director sold 1,230 shares at $26.18 ($32,196)
- 4 Planned sale CHIEF MEDICAL OFFICER sold 45,000 shares at $26.17 ($1,177,862)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF OPERATING OFFICER acquired 20,000 shares (grant or award)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 18,750 shares (grant or award)
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 25,000 shares (grant or award)
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 25,000 shares (grant or award)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 5,000 shares at $29.04 ($145,219)
Page 2 of 20 · 383 filings